Beckman Coulter's Q3 Revenues Increase 6 Percent Despite Decline in Life Science Sales

Oct 30, 2007

NEW YORK (GenomeWeb News) - Beckman Coulter today said third-quarter revenues increased 6 percent as strong sales for its clinical diagnostics were offset by lower-than-expected sales for its life science products.

Total receipts for the three months ended Sept. 30 increased to $669 million from $631.2 million year over year.

The company said it saw an increase of 9.4 percent in clinical diagnostics, while life science products declined 8.6 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu